vs

Side-by-side financial comparison of NN INC (NNBR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

NN INC is the larger business by last-quarter revenue ($104.7M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -1.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-3.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -7.0%).

NN Group N.V. is the parent company of NN Investment Partners and Nationale-Nederlanden. Nationale-Nederlanden is one of the largest insurance and asset management companies in the Netherlands. NN Group is headquartered in The Hague, its office in Rotterdam is located in the skyscraper Gebouw Delftse Poort, which was the tallest skyscraper in the Netherlands until 2009. Aside from these two offices, the company has an office in Ede but no other main offices in the Netherlands, instead NN main...

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

NNBR vs PBYI — Head-to-Head

Bigger by revenue
NNBR
NNBR
1.4× larger
NNBR
$104.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+29.4% gap
PBYI
27.7%
-1.7%
NNBR
More free cash flow
PBYI
PBYI
$17.7M more FCF
PBYI
$14.4M
$-3.3M
NNBR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-7.0%
NNBR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NNBR
NNBR
PBYI
PBYI
Revenue
$104.7M
$75.5M
Net Profit
$-12.5M
Gross Margin
69.3%
Operating Margin
-9.9%
22.7%
Net Margin
-12.0%
Revenue YoY
-1.7%
27.7%
Net Profit YoY
40.2%
EPS (diluted)
$-0.35
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NNBR
NNBR
PBYI
PBYI
Q4 25
$104.7M
$75.5M
Q3 25
$103.9M
$54.5M
Q2 25
$107.9M
$52.4M
Q1 25
$105.7M
$46.0M
Q4 24
$106.5M
$59.1M
Q3 24
$113.6M
$80.5M
Q2 24
$123.0M
$47.1M
Q1 24
$121.2M
$43.8M
Net Profit
NNBR
NNBR
PBYI
PBYI
Q4 25
$-12.5M
Q3 25
$-6.7M
$8.8M
Q2 25
$-8.1M
$5.9M
Q1 25
$-6.7M
$3.0M
Q4 24
$-21.0M
Q3 24
$-2.6M
$20.3M
Q2 24
$-2.2M
$-4.5M
Q1 24
$-12.5M
$-4.8M
Gross Margin
NNBR
NNBR
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
NNBR
NNBR
PBYI
PBYI
Q4 25
-9.9%
22.7%
Q3 25
-2.2%
17.6%
Q2 25
-1.4%
12.7%
Q1 25
-4.5%
8.7%
Q4 24
-15.8%
22.6%
Q3 24
-3.3%
27.4%
Q2 24
-1.7%
-4.6%
Q1 24
-3.9%
-5.3%
Net Margin
NNBR
NNBR
PBYI
PBYI
Q4 25
-12.0%
Q3 25
-6.4%
16.2%
Q2 25
-7.5%
11.2%
Q1 25
-6.3%
6.5%
Q4 24
-19.7%
Q3 24
-2.3%
25.2%
Q2 24
-1.8%
-9.6%
Q1 24
-10.3%
-11.0%
EPS (diluted)
NNBR
NNBR
PBYI
PBYI
Q4 25
$-0.35
$0.26
Q3 25
$-0.23
$0.17
Q2 25
$-0.26
$0.12
Q1 25
$-0.23
$0.06
Q4 24
$-0.52
$0.40
Q3 24
$-0.13
$0.41
Q2 24
$-0.12
$-0.09
Q1 24
$-0.34
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NNBR
NNBR
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$11.4M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$34.0M
$130.3M
Total Assets
$440.8M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NNBR
NNBR
PBYI
PBYI
Q4 25
$11.4M
$97.5M
Q3 25
$12.2M
$94.4M
Q2 25
$9.5M
$96.0M
Q1 25
$11.7M
$93.2M
Q4 24
$18.1M
$101.0M
Q3 24
$12.4M
$96.7M
Q2 24
$13.7M
$96.8M
Q1 24
$20.6M
$107.2M
Total Debt
NNBR
NNBR
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
NNBR
NNBR
PBYI
PBYI
Q4 25
$34.0M
$130.3M
Q3 25
$49.6M
$115.3M
Q2 25
$59.5M
$104.7M
Q1 25
$67.3M
$97.1M
Q4 24
$74.5M
$92.1M
Q3 24
$106.6M
$71.1M
Q2 24
$108.4M
$48.5M
Q1 24
$116.1M
$51.0M
Total Assets
NNBR
NNBR
PBYI
PBYI
Q4 25
$440.8M
$216.3M
Q3 25
$451.0M
$202.9M
Q2 25
$460.8M
$194.9M
Q1 25
$460.7M
$196.2M
Q4 24
$456.9M
$213.3M
Q3 24
$483.1M
$220.7M
Q2 24
$497.2M
$205.0M
Q1 24
$512.8M
$214.1M
Debt / Equity
NNBR
NNBR
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NNBR
NNBR
PBYI
PBYI
Operating Cash FlowLast quarter
$-1.5M
$14.4M
Free Cash FlowOCF − Capex
$-3.3M
$14.4M
FCF MarginFCF / Revenue
-3.2%
19.1%
Capex IntensityCapex / Revenue
1.8%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.2M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NNBR
NNBR
PBYI
PBYI
Q4 25
$-1.5M
$14.4M
Q3 25
$11.2M
$9.7M
Q2 25
$-696.0K
$14.1M
Q1 25
$-3.3M
$3.6M
Q4 24
$6.7M
$15.6M
Q3 24
$5.0M
$11.0M
Q2 24
$-1.3M
$1.0M
Q1 24
$712.0K
$11.2M
Free Cash Flow
NNBR
NNBR
PBYI
PBYI
Q4 25
$-3.3M
$14.4M
Q3 25
$7.7M
$9.7M
Q2 25
$-4.4M
$14.1M
Q1 25
$-7.3M
$3.6M
Q4 24
$3.7M
$15.6M
Q3 24
$-1.3M
$11.0M
Q2 24
$-4.9M
$1.0M
Q1 24
$-4.7M
FCF Margin
NNBR
NNBR
PBYI
PBYI
Q4 25
-3.2%
19.1%
Q3 25
7.4%
17.7%
Q2 25
-4.1%
26.8%
Q1 25
-6.9%
7.7%
Q4 24
3.5%
26.4%
Q3 24
-1.2%
13.7%
Q2 24
-4.0%
2.1%
Q1 24
-3.9%
Capex Intensity
NNBR
NNBR
PBYI
PBYI
Q4 25
1.8%
0.0%
Q3 25
3.3%
0.0%
Q2 25
3.4%
0.0%
Q1 25
3.7%
0.1%
Q4 24
2.8%
0.0%
Q3 24
5.5%
0.0%
Q2 24
2.9%
0.0%
Q1 24
4.5%
0.0%
Cash Conversion
NNBR
NNBR
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NNBR
NNBR

Automotive$53.1M51%
Power Solutions$45.5M43%
Other End Market$4.7M4%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons